A significant advance in cancer study is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This essential malignant protector protein is frequently disabled in various forms of tumors, resulting https://bookmarkdistrict.com/story21665494/vhh-fragments-revive-tumor-suppressor-p53-a-promising-approach-for-cancer-therapy